81 related articles for article (PubMed ID: 10052990)
1. Development of HPLC conditions for valid determination of hydrolysis products of cisplatin.
El-Khateeb M; Appleton TG; Charles BG; Gahan LR
J Pharm Sci; 1999 Mar; 88(3):319-26. PubMed ID: 10052990
[TBL] [Abstract][Full Text] [Related]
2. Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.
el-Khateeb M; Appleton TG; Gahan LR; Charles BG; Berners-Price SJ; Bolton AM
J Inorg Biochem; 1999 Oct; 77(1-2):13-21. PubMed ID: 10626348
[TBL] [Abstract][Full Text] [Related]
3. Influence of dT20 and [d(AT)10]2 on cisplatin hydrolysis studied by two-dimensional [1H,15N] HMQC NMR spectroscopy.
Vinje J; Sletten E; Kozelka J
Chemistry; 2005 Jun; 11(13):3863-71. PubMed ID: 15827978
[TBL] [Abstract][Full Text] [Related]
4. Specific determination of intact cisplatin and monohydrated cisplatin in human plasma and culture medium ultrafiltrates using HPLC on-line with inductively coupled plasma mass spectrometry.
Bell DN; Liu JJ; Tingle MD; McKeage MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):29-34. PubMed ID: 16697278
[TBL] [Abstract][Full Text] [Related]
5. A complete kinetic study of GG versus AG plantination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species.
Legendre F; Bas V; Kozelka J; Chottard JC
Chemistry; 2000 Jun; 6(11):2002-10. PubMed ID: 10894399
[TBL] [Abstract][Full Text] [Related]
6. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples.
Lopez-Flores A; Jurado R; Garcia-Lopez P
J Pharmacol Toxicol Methods; 2005; 52(3):366-72. PubMed ID: 16112590
[TBL] [Abstract][Full Text] [Related]
7. High performance liquid chromatographic separation of cisplatin and its hydrolysis products on alumina and application to studies of their interaction with cysteine.
Shearan P; Alvarez JM; Zayed N; Smyth MR
Biomed Chromatogr; 1990 Mar; 4(2):78-82. PubMed ID: 2350603
[TBL] [Abstract][Full Text] [Related]
8. The integrity of cisplatin in aqueous and plasma ultrafiltrate media studied by 195Pt and 15N nuclear magnetic resonance.
Brière KM; Goel R; Shirazi FH; Stewart DJ; Smith CP
Cancer Chemother Pharmacol; 1996; 37(6):518-24. PubMed ID: 8612304
[TBL] [Abstract][Full Text] [Related]
9. A Novel Analytical Method of Cisplatin Using the HPLC with a Naphthylethyl Group Bonded with Silica Gel (πNAP) Column.
Kato R; Sato T; Kanamori M; Miyake M; Fujimoto A; Ogawa K; Kobata D; Fujikawa T; Wada Y; Mitsuishi R; Takahashi K; Imano H; Ijiri Y; Mino Y; Chikuma M; Tanaka K; Hayashi T
Biol Pharm Bull; 2017 Mar; 40(3):290-296. PubMed ID: 27980242
[TBL] [Abstract][Full Text] [Related]
10. Comparison between HPLC and capillary electrophoresis for the separation and identification of the platination products of oligonucleotides with cis-[Pt(NH3)2(H2O)2]2+ and [Pt(NH3)3(H2O)]2+.
Troujman H; Chottard JC
Anal Biochem; 1997 Oct; 252(1):177-85. PubMed ID: 9324957
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a mixed-model stationary phase derived from glutamine for HPLC separation of structurally different biologically active compounds: HILIC and reversed-phase applications.
Aral T; Aral H; Ziyadanoğulları B; Ziyadanoğulları R
Talanta; 2015 Jan; 131():64-73. PubMed ID: 25281074
[TBL] [Abstract][Full Text] [Related]
12. Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.
Tacka KA; Szalda D; Souid AK; Goodisman J; Dabrowiak JC
Chem Res Toxicol; 2004 Nov; 17(11):1434-44. PubMed ID: 15540941
[TBL] [Abstract][Full Text] [Related]
13. Use of binary and ternary mobile phases in reversed-phase high performance liquid chromatographic separation of chiral compounds.
Gołkiewicz W; Błazewicz A; Matosiuk D
J Sep Sci; 2004 Mar; 27(4):304-10. PubMed ID: 15334918
[TBL] [Abstract][Full Text] [Related]
14. Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection.
Cios A; Kuś K; Szymura-Oleksiak J
Acta Pol Pharm; 2013; 70(4):631-41. PubMed ID: 23923387
[TBL] [Abstract][Full Text] [Related]
15. Computational consideration of cisplatin hydrolysis and acid dissociation in aqueous media: effect of total drug concentrations.
Yotsuyanagi T; Usami M; Noda Y; Nagata M
Int J Pharm; 2002 Oct; 246(1-2):95-104. PubMed ID: 12270612
[TBL] [Abstract][Full Text] [Related]
16. A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions.
Jain R; Wu Z; Tucker IG
J Pharm Biomed Anal; 2009 Dec; 50(5):841-6. PubMed ID: 19640667
[TBL] [Abstract][Full Text] [Related]
17. Determination of the acid dissociation constant for cis-diammineaquachloroplatinum(II) ion. A hydrolysis product of cisplatin.
Andersson A; Hedenmalm H; Elfsson B; Ehrsson H
J Pharm Sci; 1994 Jun; 83(6):859-62. PubMed ID: 9120821
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cisplatin with methionine- and histidine-containing peptides: competition between backbone binding, macrochelation and peptide cleavage.
Hahn M; Kleine M; Sheldrick WS
J Biol Inorg Chem; 2001 Jun; 6(5-6):556-66. PubMed ID: 11472019
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of RP-HPLC method for cetrimonium bromide and lidocaine determination.
Malenovic A; Medenica M; Ivanovic D; Jancic B; Markovic S
Farmaco; 2005 Feb; 60(2):157-61. PubMed ID: 15752474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
